JD Health International Inc. (6618.HK)
- Previous Close
26.550 - Open
26.800 - Bid 25.300 x --
- Ask 25.400 x --
- Day's Range
25.300 - 26.800 - 52 Week Range
22.350 - 59.600 - Volume
13,243,887 - Avg. Volume
7,192,807 - Market Cap (intraday)
80.694B - Beta (5Y Monthly) 0.83
- PE Ratio (TTM)
33.73 - EPS (TTM)
0.750 - Earnings Date Aug 14, 2024 - Aug 19, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
44.15
JD Health International Inc., an investment holding company, engages in the operation of an online healthcare platform in the People's Republic of China and internationally. It offers pharmaceutical and healthcare products through direct selling and an online retail pharmacy network. The company also provides online medical consultation, consumer healthcare, and health management services; hospital or doctor referral, health check-ups, genetic testing, and beauty care services; and intelligent healthcare solutions, as well as technical and advertising services. The company was incorporated in 2018 and is headquartered in Beijing, the People's Republic of China. JD Health International Inc. is a subsidiary of JD Jiankang Limited.
ir.jdhealth.com3,118
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: 6618.HK
Performance Overview: 6618.HK
Trailing total returns as of 6/7/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 6618.HK
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 6618.HK
Valuation Measures
Market Cap
80.69B
Enterprise Value
35.63B
Trailing P/E
33.86
Forward P/E
37.74
PEG Ratio (5yr expected)
2.12
Price/Sales (ttm)
1.36
Price/Book (mrq)
1.49
Enterprise Value/Revenue
0.61
Enterprise Value/EBITDA
11.07
Financial Highlights
Profitability and Income Statement
Profit Margin
4.00%
Return on Assets (ttm)
0.63%
Return on Equity (ttm)
4.55%
Revenue (ttm)
53.53B
Net Income Avi to Common (ttm)
2.14B
Diluted EPS (ttm)
0.750
Balance Sheet and Cash Flow
Total Cash (mrq)
41.22B
Total Debt/Equity (mrq)
0.44%
Levered Free Cash Flow (ttm)
2.75B